Literature DB >> 19310522

Endocrine aspects of advanced mammary cancer.

R B Welbourn.   

Abstract

Entities:  

Year:  1967        PMID: 19310522      PMCID: PMC2312286     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


× No keyword cloud information.
  8 in total

1.  Factors influencing response to hypophysectomy for advanced cancer of breast.

Authors:  A MCCALISTER; R B WELBOURN; G J EDELSTYN; A R LYONS; A R TAYLOR; C A GLEADHILL; D S GORDON; J O COLE
Journal:  Br Med J       Date:  1961-03-04

2.  Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone.

Authors:  R D BULBROOK; F C GREENWOOD; J L HAYWARD
Journal:  Lancet       Date:  1960-05-28       Impact factor: 79.321

3.  Screw-implantation of the pituitary with yttrium-90.

Authors:  A P FORREST; D W BLAIR; J M VALENTINE
Journal:  Lancet       Date:  1958-07-26       Impact factor: 79.321

4.  Radioactive isotopes and nuclear radiations in the treatment of cancer.

Authors:  J H LAWRENCE; C A TOBIAS
Journal:  Cancer Res       Date:  1956-03       Impact factor: 12.701

5.  Clinical studies in advanced breast cancer.

Authors:  A P Forrest
Journal:  J R Coll Surg Edinb       Date:  1967-04

6.  A rational approach to hypophysectomy.

Authors:  G Edelstyn; C Gleadhill; A Lyons
Journal:  Br J Surg       Date:  1965-12       Impact factor: 6.939

7.  The timing of adrenalectomy and of hypophysectomy in the treatment of advanced breast cancer.

Authors:  H Atkins; M A Falconer; J L Hayward; K S MacLean; P H Schurr
Journal:  Lancet       Date:  1966-04-16       Impact factor: 79.321

8.  An evaluation of therapeutic surgical castration in the treatment of metastatic, recurrent, and primary inoperable mammary carcinoma in women; an analysis of 191 patients.

Authors:  N TREVES; J A FINKBEINER
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.